ArticleArthritis research & therapy2018

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Florian Weigold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.